Sell AbbVie Stock Ahead of Its Upcoming Earnings?

Core Insights - AbbVie is set to release its earnings report on July 31, 2025, with current consensus estimates projecting earnings of $2.91 per share on sales of $15.03 billion, compared to $2.65 per share on sales of $14.46 billion in the same quarter last year [3][4] Historical Performance - Over the past five years, AbbVie has experienced a negative one-day return following earnings announcements in 65% of instances, with a median decline of -1.3% and a maximum drop of -7.3% [3][7] - There have been 20 earnings data points recorded over the last five years, with 7 positive and 13 negative one-day returns, resulting in positive returns approximately 35% of the time; this percentage decreases to 17% when considering the last 3 years [7] Financial Metrics - AbbVie currently has a market capitalization of $333 billion, with $57 billion in revenue, $13 billion in operating profits, and a net income of $4.2 billion over the last twelve months [4] Trading Strategies - Traders can analyze historical probabilities and take positions before earnings releases, as well as examine correlations between immediate and medium-term returns post-earnings to adjust positions accordingly [6][8]